Urinalysis Market

Urinalysis Market worth $6.8 billion by 2029

The report "Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029", is valued at an estimated USD 4.3 billion in 2024 and is projected to reach USD 6.8 billion by 2029 at a CAGR of 9.6% during the forecast period.

Browse 483 market data Tables and 49 Figures spread through 390 Pages and in-depth TOC on "Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html

There is a growing need for efficient and accurate diagnostic methods such as urinalysis to facilitate early detection, monitoring, and management of health conditions such as urinary tract infections (UTIs), diabetes, liver diseases, kidney diseases, and bladder cancer. As the burden of these diseases continues to grow, the urinalysis market is poised for sustained expansion to meet the evolving needs of patients and healthcare providers alike. However, the availability of refurbished urine analyzers may restrain market growth to a certain extent.

In 2023, the consumables segment held the largest share of the urinalysis market by product segment.

Based on product, the urinalysis market is segmented into consumables and instruments. The consumables segment dominated the urinalysis market in 2023 due to its recurrent purchase requirement. Consumables such as kits, test strips, reagents, and disposables are used in every urinalysis test, making their demand continuous and high. Each test requires fresh consumables, driving their recurrent use across various settings.

The pregnancy & fertility tests segment held the largest share of the urinalysis market by test type segment in 2023.

Based on test type, the urinalysis market is segmented into biochemical tests, sediment urinalysis, and pregnancy & fertility tests. In 2023, largest share of the urinalysis market was held by the pregnancy & fertility tests segment. Technological advancements have enhanced the accuracy, ease of use, and speed of these tests, making them more reliable and user-friendly. The competitive landscape, marked by continuous investment in R&D by key players, drives innovation and market expansion, while regulatory standards ensure safety and efficacy, instilling consumer confidence.

North America is the largest regional market for urinalysis market.

The market for urinalysis has been divided into six key geographical regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. In 2023, North America held the predominant portion of the urinalysis market. The region boasts a well-developed healthcare infrastructure, including advanced diagnostic facilities, and a skilled workforce. This infrastructure supports the integration of urinalysis into routine clinical practice, facilitating access for patients across various healthcare settings. The region has a high adoption rate of cutting-edge medical technologies, including sophisticated urinalysis equipment. These advancements improve diagnostic accuracy and efficiency, making urinalysis a preferred diagnostic tool in many healthcare settings. Also, North America has a high prevalence of chronic diseases such as diabetes and kidney disorders, which require regular monitoring through urinalysis.

The major players operating in this market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), Danaher (US), Sysmex Corporation (Japan), Thermo Fisher Scientific Inc. (US), QuidelOrtho Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics Holdings plc (UK), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (US), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Co., Ltd. (China), DIRUI INDUSTRIAL CO., LTD. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), Erba Mannheim (UK), Alphatec Scientific E.I.R.L. (Peru), Teco Diagnostics (US), Analyticon Biotechnologies GmbH (Germany), Bioway Biological Technology Co., Ltd. (China), High Technology, Inc. (US), Agappe Diagnostics Ltd. (India), TOYOBO CO., LTD. (Japan), DIALAB GmbH (Austria), Quantimetrix (US), BioCare Corporation (Taiwan), Randox Laboratories Ltd. (Ireland), PZ Cormay S.A. (Poland), YD Diagnostics (South Korea), CONTEC MEDICAL SYSTEMS CO., LTD. (China), and Biopanda Reagents Ltd. (UK).

Don’t miss out on business opportunities in Urinalysis Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Urinalysis Market Size,  Share & Growth Report
Report Code
MD 3259
PR Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Urinalysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status

Digital Virtual Assistant - MarketsandMarkets